NCT01820481View on ClinicalTrials.gov

Safety and Efficacy of WIN-901X in Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Asthma
Interventions
DRUG

WIN-901X dose level 1

100mg Bid, PO, 12weeks

DRUG

WIN-901X dose level 2

200mg Bid, PO, 12weeks

DRUG

WIN-901X dose level 3

300mg Bid, PO, 12weeks

DRUG

Placebo

Bid, PO, 12weeks

Trial Locations (1)

Unknown

Ajou University Medical Center, Suwon

All Listed Sponsors
lead

Whanin Pharmaceutical Company

INDUSTRY

NCT01820481 - Safety and Efficacy of WIN-901X in Asthma | Biotech Hunter | Biotech Hunter